Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group studyTodd Hulgan, Jeffrey A. Canter, David W. Haas et al.|AIDS|2005Cited by 146
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapyAsha Kallianpur, David W. Haas, Todd Hulgan et al.|AIDS|2006Cited by 62
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathyJeffrey A. Canter, Todd Hulgan, David W. Haas et al.|The Pharmacogenomics Journal|2007Cited by 61
Hemochromatosis Gene Polymorphisms, Mitochondrial Haplogroups, and Peripheral Lipoatrophy during Antiretroviral TherapyTodd Hulgan, Asha Kallianpur, Pablo Tebas et al.|The Journal of Infectious Diseases|2008Cited by 54
Pharmacogenetics of Nucleoside Reverse-Transcriptase Inhibitor-Associated Peripheral NeuropathyAsha Kallianpur, Todd Hulgan|Pharmacogenomics|2009Cited by 45